Posted January 19, 2011
Compass Leads Consortium to Acquire 100% of Rameda Pharmaceutical
The acquisition gives Compass exposure to a defensive and fast-growing pharmaceutical industry with significant upside potential
private equity delivered by industry-leading professionals
of our market and its business environment
of unlocking value in MENA markets
Driving lasting value growth for all stakeholders
of talented management to drive growth
leveraging more than 100 combined years of experience
browse through our latest news
The acquisition gives Compass exposure to a defensive and fast-growing pharmaceutical industry with significant upside potential